InfliximabVarious infusion-related reactions: 6 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-021-90633-x
中图分类号
学科分类号
摘要
引用
下载
收藏
页码:131 / 131
相关论文
共 50 条
  • [22] INFUSION-RELATED REACTIONS WITH OCRELIZUMAB IN RMS AND PPMS
    de Seze, Jerome
    Bar-Or, Amit
    Giovannoni, Gavin
    Hemmer, Bernhard
    Kappos, Ludwig
    Lublin, Fred
    Wolinsky, Jerry
    Li, Carrie
    Mairon, Nicole
    Hauser, Stephen L.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A46 - A46
  • [24] Incidence and Management of Olaratumab Infusion-Related Reactions
    Van Tine, Brian A.
    Govindarajan, Rangaswamy
    Attia, Steven
    Somaiah, Neeta
    Barker, Scott S.
    Shahir, Ashwin
    Barrett, Emily
    Lee, Pablo
    Wacheck, Volker
    Ramage, Samuel C.
    Tap, William D.
    JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (11) : 592 - +
  • [25] Successful rechallenge of cetuximab following severe infusion-related reactions: a case report
    Chang, Pei-Hung
    Huang, Jen-Seng
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (01) : E10 - E12
  • [28] Infusion-related hypersensitivity reactions during natalizumab treatment
    Phillips, J. T.
    O'Connor, P. W.
    Havrdova, E.
    Hutchinson, M.
    Kappos, L.
    Miller, D. H.
    Polman, C. H.
    Lublin, F. D.
    Giovannoni, G.
    Wajgt, A.
    Lynn, F.
    Panzara, M. A.
    NEUROLOGY, 2006, 67 (09) : 1717 - 1718
  • [29] Infusion-related reactions with ocrelizumab in phase III studies
    de Seze, J.
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Pozzilli, C.
    Chognot, C.
    Julian, L.
    Koendgen, H.
    Zheng, H.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 878 - 879
  • [30] Optimizing Premedications in the Prevention of Bendamustine Infusion-Related Reactions
    Tombleson, Rebecca L.
    Viet Ho
    Sokol, Lubomir
    Pinilla, Javier
    Wetzstein, Gene A.
    CANCER CONTROL, 2012, 19 (03) : 245 - 247